Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

620.80DKK
19 Jun 2018
Change (% chg)

kr.-5.60 (-0.89%)
Prev Close
kr.626.40
Open
kr.623.40
Day's High
kr.624.40
Day's Low
kr.617.80
Volume
289,556
Avg. Vol
364,089
52-wk High
kr.644.80
52-wk Low
kr.474.30

Chart for

About

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)

Overall

Beta: 1.09
Market Cap(Mil.): kr.125,300.50
Shares Outstanding(Mil.): 198.00
Dividend: 5.00
Yield (%): 2.47

Financials

  COLOb.CO Industry Sector
P/E (TTM): 35.26 40.33 34.14
EPS (TTM): 17.77 -- --
ROI: 65.26 14.36 13.17
ROE: 72.38 17.58 15.14

BRIEF-Coloplast Q2 EBIT at DKK 1.20 bln

* REG-ANNOUNCEMENT NO. 4/2018 - INTERIM FINANCIAL REPORT, H1 2017/18

May 03 2018

BRIEF-Coloplast Launches Share Buy-Back Programme

* ‍FIRST PART OF PROGRAMME, OF DKK 500M, EXPECTED TO TAKE PLACE DURING PERIOD FROM 26 FEB 2018 TO 25 AUG 2018​

Feb 20 2018

BRIEF-Coloplast Acquires IncoCare in Germany

* COLOPLAST - TRANSACTION WILL NOT IMPACT COLOPLAST'S FINANCIAL GUIDANCE FOR 17/18. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 07 2018

BRIEF-Coloplast CFO Says Greek Authorities Have Reduced Prices In Our Segments By Around 25 Percent Final Price Settlement Due After Appeal Period

Feb 1 COLOPLAST CHIEF FINANCIAL OFFICER ANDERS LONNING-SKOVGAARD SAYS IN TELEPHONE INTERVIEW:

Feb 01 2018

BRIEF-Coloplast Q1 EBIT Below Expectations At DKK 1.21 Billion

* REG-ANNOUNCEMENT NO. 02/2018 - Q1 INTERIM FINANCIAL REPORT, 2017/18

Feb 01 2018

Earnings vs. Estimates